CTRI/2018/03/012711招募中2 期
A prospective open labeled randomized clinical trial on Cegana Vatham (Cervical Spondylosis) with evaluation of trial drug "Inji Chooranam "
Dr S Neelavathi1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年8月7日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- The therapeutic efficacy of trial drug Inji Chooranam on Cegana Vatham
研究概览
简要总结
The study is prospective open Labeled randomized phase II clinical trial to evaluate the therapeutic efficacy of Inji Chooranam 1g bd with warm water for 48 days in 40 Patients during the trial period of 6 months that will be conducted in Government Siddha Medical college and hospital Palayamkottai Tamilnadu The primary outcome will be the therapeutic efficacy of trial drug Inji Chooranam on Cegana Vatham The secondary outcome will be the evaluation of Siddha diagnostic parameters
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient with appropriate symptoms of neck pain radiating to upper limb with or without numbness giddiness neck stiffness and restricted neck movements Willing for doing laboratory investigations and x Ray imaging Neck stability index score should be equal or greater than 60%.
排除标准
- •Extra cervical rib trauma Systemic hypertension Diabetes mellitus Chronic kidney disease Tuberculosis in spine Ischemic heart disease Pregnancy Lactating mother Neoplasams Patient with any other chronic illness Systemic illness Congenital spinal anomalies Malignancy secondaries.
结局指标
主要结局
The therapeutic efficacy of trial drug Inji Chooranam on Cegana Vatham
时间窗: 48 days
次要结局
- Evaluation of Siddha diagnostic parameters(48 days)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
2 期
Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL： A Randomized, Open Phase II TrialMarginal Zone Lymphoma(MZL)NCT06700798Fei Li90
Unknown
2 期
OPTmizing Advanced Stage HodgkIn LymphoMa patIentS TherapyClassical Hodgkin LymphomaHodgkin Lymphoma (Category)Hodgkin DiseaseHodgkin LymphomaNCT03527628King Abdullah International Medical Research Center220
已完成
2 期
Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid LeukemiaNewly Diagnosed Secondary or High Risk AMLNCT04230239PETHEMA Foundation59
已完成
2 期
A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis BChronic Hepatitis BNCT02332473Xiamen Amoytop Biotech Co., Ltd.110
撤回
2 期
Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS)Disorder Related to Lung TransplantationChronic Rejection of Lung TransplantDecreased Immunologic ActivityNCT04415476University of Maryland, Baltimore